CDMO: חובות מצטברים של החברה Avid Bioservices
The market value dynamics of the asset on the GURU.Markets platform show figures at 0.19. Avid Bioservices, Inc. (CDMO) generates revenue from the production of antibodies and biologics, relying on a broad client base ranging from small firms to tech giants. Growth is driven by US protectionism and the West's pursuit of autonomy. High customer loyalty is ensured by rigorous quality control and the complexity of switching certified suppliers.
פילוחים אנליטיים ודוחות נתונים של חברת Avid Bioservices (CDMO)
By diversifying its order book through contract manufacturing for numerous pharmaceutical companies, Avid Bioservices, Inc. (CDMO) optimizes operational risks. An analysis of net total debt, combining loan obligations and bonds, allows for an assessment of financial leverage and the speed of resource mobilization for scaling, while the total debt trajectory serves as an indicator of the business's resilience to shifting market cycles.